Consistent with our previous findings that rGSK‐3β has the highest efficiency in identifying MCI from T2DM patients, compared with other characteristic factors, such as aging, ApoE genetype, and olfaction (Z. P. Xu et al., 2016), we confirmed the role of rGSK‐3β in the current study. Here, APOE is linked to type 2 diabetes mellitus.